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Summary
To investigate the precise role of Notch/Rbp-j signaling in the pancreas, we inactivated Rbp-j by crossing Rbp-j floxed mice
with Pdx.cre orRip.cre transgenic mice. The loss of Rbp-j at the initial stage of pancreatic development induced accelerated
a andPP cell differentiation and a concomitant decrease in the number of Neurogenin3 (Ngn3)-positive cells at E11.5. Then at
E15, elongated tubular structures expressing ductal cell markers were evident; however, differentiation of acinar and all
types of endocrine cells were reduced. During later embryonic stages, compensatory acinar cell differentiation was ob-
served. The resultant mice exhibited insulin-deficient diabetes with both endocrine and exocrine pancreatic hypoplasia. In
contrast, the loss of Rbp-j specifically in b cells did not affect b cell number and function. Thus, our analyses indicate that
Notch/Rbp-j signaling prevents premature differentiation of pancreatic progenitor cells into endocrine and ductal cells dur-
ing early development of the pancreas.Introduction
The pancreas plays a key role in the maintenance of nutritional
homeostasis through its exocrine and endocrine functions. The
acini and ducts form the exocrine pancreas that produces and
transports digestive enzymes into the duodenum.Besides, there
are five known endocrine cell types in the pancreas: glucagon-
producing a cells, insulin-producing b cells, somatostatin-pro-
ducing d cells, pancreatic polypeptide (PP)-producing PP cells,
and ghrelin-producing 3 cells (Heller et al., 2005).
Notch signaling regulates various developmental processes,
such as neurogenesis, somitogenesis, angiogenesis, and hema-
topoiesis (Ishibashi et al., 1995; Hrabe´ de Angelis et al., 1997;
Xue et al., 1999; Han et al., 2002). Interaction of a Notch receptor
with its ligand induces cleavage of the receptor’s intracellular
domain (Notch ICD),which translocates to the nucleus andbinds
to Rbp-j to induce the expression of Hes family transcriptional
repressors (Kageyama and Ohtsuka, 1999). Rbp-j is a key medi-
ator of Notch signaling because it is expressed ubiquitously and
associates with all four types of Notch receptors (Kato et al.,
1996). Various Notch-related genes are expressed in the devel-
oping pancreas (Lammert et al., 2000). However, multiple anom-
alies and early embryonic lethalities of mice with homozygous
deletions of genes such as Dll1, Notch1, Notch2, Jagged1,
Rbp-j, or Hes1 limits assessment of the importance of Notch/
Rbp-j signaling in the pancreas (Swiatek et al., 1994; Ishibashi
et al., 1995; Oka et al., 1995; Hrabe´ de Angelis et al., 1997;
Apelqvist et al., 1999; Hamada et al., 1999; Xue et al., 1999; Jen-
sen et al., 2000a). Although excess a cell differentiation in the
pancreas has been reported at around E10 in mice with a gener-
alized KO of Dll1 or Hes1 (Apelqvist et al., 1999; Jensen et al.,
2000a), because b cells start to expand at around E13 and their
differentiation occurs independently of a cells (Jensen et al.,CELL METABOLISM 3, 59–65, JANUARY 2006 ª2006 ELSEVIER INC.2000b), the influence of Notch signaling on b cells remains to
be elucidated. To address this issue, we created mice with de-
velopmental stage-specific deletion of Rbp-j in the pancreas
using the Cre/loxP-mediated DNA recombination system.
Results
Accelerated premature differentiation of a and PP cells
but not of b, d, and 3 cells in pancreatic Rbp-j KO
(PRKO) mice
By crossing floxed Rbp-j (Rbp-jf/f, designated as F/F) mice with
Pdx.cre mice, we generated pancreatic Rbp-j KO (Rbp-jf/f
Pdx.cre, designated as PRKO) mice (Gu et al., 2002; Han et al.,
2002; see the Supplemental Data available with this article on-
line). The Pdx.cre mouse begins to recombine loxP sites in the
pancreatic epithelium before E9.5 (Figure S1B). Notch signaling
negatively regulates proneural basic helix-loop-helix (bHLH)
factors through Hes activation (Kageyama and Ohtsuka, 1999).
A unique proendocrine bHLH transcription factor, Ngn3, is re-
quired for the development of pancreatic endocrine lineages
(Gradwohl et al., 2000; Gu et al., 2002). We observed a prema-
ture increase in the number of Ngn3+ cells in the pancreatic buds
of PRKO mice (Figure S2A). At E11.5, a few scattered a cells
among the protruding epithelial cells of F/F mice were observed
(Figures 1E and 1E0). In PRKOmice, the number of a and PP cells
increased and they surrounded the pancreatic buds (Figures 1F,
1F0, 1J, and 1J0). However, b, d, and ghrelin-producing cell differ-
entiation was not enhanced in the mutants (Figures 1D, 1D0, 1H,
1H0, and S3B). The number of Ngn3+ cells decreased in PRKO
mice compared with control mice (Figures 1M–1N0 and S2B).
The number of proliferating cells detected by phosphohistone
H3 (pHH3) immunostaining was comparable between control
and mutant mice (Figures 1O–1P0). No apoptotic cells wereDOI 10.1016/j.cmet.2005.12.005 59
S H O R T A R T I C L EFigure 1. Accelerated premature differentiation of a and PP cells but not b, d, and 3 cells in pancreatic Rbp-j KO (PRKO) mice
A–P0) HE staining (A–B0), and immunostaining (C–P0) of representative serial pancreatic sections from F/F mice and PRKO mice at E11.5.detected in the pancreatic epithelia of control or mutant mice
(Figures S3C–S3E). These data indicate that earlier commitment
to proendocrine (Ngn3+) cells induced by defective Notch sig-
naling results in precocious endocrine cell differentiation and
a substantial loss of proendocrine cells during early pancreatic
development.
Elongated tubular structures with decreased branching
morphogenesis in the pancreas of the PRKO mouse
At E15, pancreatic Pdx1+ epithelium of control mice exhibited
complex and ramified networks (Figure 2B). However, in themu-
tant, branching of Pdx1+ epithelium was severely impaired, and
dilated tubular structures were prominent (Figure 2B0). The de-
creased epithelial branching was not associated with increased
cell death or decreased proliferation, because these cells were
not apoptotic (Figure 2D0), but exhibited active division (Fig-
ure 2M0). Moreover, acinar and b cells were scarcely differenti-
ated (Figures 2C0 and 2H0), and aggregated a cells existed
around the columnar tubular epithelium (Figure 2G0). The cells
lining the lumens of tubular structures showed positive staining
with cytokeratin (CK) and Dolichos biflorus agglutinin (DBA) lec-
tin (Dor et al., 2004) (Figures 2K–2L0). The glucose transporter 2
(Glut2), expressed on the surface of differentiated b cells (Fig-
ure 2N), is also thought to be a marker of early pancreatic pro-
genitor cells (Pang et al., 1994); however, Glut2 was not ex-
pressed in the tubular epithelium (Figure 2N0). In the control
pancreas, Hes1 expression was not detected (Figure 2O), but
scattered Ngn3+ cells were evident at this stage (Figure 2P). In
themutant pancreas, expression ofHes1 andNgn3was virtually
absent (Figures 2O0 and 2P0). ISL1 is a LIM homeodomain pro-
tein whose expression is initiated after Ngn3 extinction but be-
fore hormone production (Ahlgren et al., 1997). ISL1 expression
was not detected in the tubular epithelium (Figure 2Q0). This
analysis of various differentiation markers shows that the cells60lining these tubular structures are not early progenitors, nor
are they on the endocrine lineage. The tubular morphologies
and high columnar epithelium resembling that of the large pan-
creatic duct rather suggest that the cells positive for ductal
markers are duct cells. We confirmed that all of these cells were
derived from Rbp-j-deficient cells by lineage tracing (Figure S4).
At later embryonic stages of PRKO mice, the acinar cell area
was much smaller and CK+ ductal cells occupied a larger area
compared with F/F mice (Figures S5A–S5F). Although compen-
satory acinar growth was observed (Figures S5E–S5H), the in-
terval sections revealed a much smaller pancreas in the mutant
than in the control mouse (Figure S5I).
PRKO mice are born with pancreatic hypoplasia
and exhibit insulin-deficient diabetes
The adult PRKO mouse exhibited a small pancreas (Figure 3A).
The absolute pancreatic weight (PRKO, 2096 73mg versus F/F,
685 6 81 mg; p = 0.0038; Figure 3B) and the ratio of pancreatic
weight to total bodyweight (data not shown) were lower in PRKO
mice than in F/F mice. In pancreatic sections from PRKO mice,
the number of islets per pancreas area was reduced (PRKO,
0.15 6 0.06 versus F/F, 0.62 6 0.13 islets/mm2; p = 0.015; Fig-
ures 3C and 3D), and the size of the islets was smaller compared
with F/F mice (Figure 3C). The relative endocrine cell mass was
quantifiedbyestimating thehormone-positive areaper total pan-
creatic area inmultiplepancreatic sections. Thebcellmassof the
PRKO mice was markedly reduced to about 25% of the b cell
mass of F/F mice (PRKO, 0.21 6 0.08% versus F/F, 1.13 6
0.04%; p < 0.001; Figure 3E), and the absolute a cell mass was
also significantly reduced to about 50% of that of the F/F mice
(PRKO, 0.11 6 0.02% versus F/F, 0.24 6 0.02%; p < 0.001;
Figure 3E). Total pancreatic insulin content (expressed per mg of
pancreas weight) estimated from an acid-ethanol extract of the
whole pancreas. PRKO mice had much lower insulin contentsCELL METABOLISM : JANUARY 2006
Role of Rbp-j in pancreas developmentFigure 2. Elongated tubular structures with decreased branching in PRKO mice at E15
A–J0) Dilated and elongated duct-like structures in PRKO mice. HE staining (A and A0), immunostaining (B–C0 and F–J0), and TUNEL assay (D and D0) of serial pancreatic
sections from F/F mice and PRKO mice at E15. The mammary gland of a postlactating female Wistar rat was used as a positive control for apoptosis (E).
K–Q0) Characterization of duct-like cells in PRKO mice. Immunostaining (K–N0, P–Q0) and Hes1 in situ hybridization (O and O0 ) of pancreatic sections from F/F and PRKO
mice at E15.than the F/F mice (PRKO, 0.96 0.2 pg/mg pancreas versus F/F,
96.46 9.9 pg/mg pancreas; p < 0.001; Figure 3F). In addition to
the scarcity of islets, histological analysis of the adult pancreas in
PRKOmice revealed that the endocrine cellswere frequently ob-
served in association with distended pancreatic ducts (Figures
3J, 3L, 3N, 3P, and 3R). The relative ductal hyperplasia observed
during the embryonic stages of PRKOmice (FigureS5D) became
obscured in adult PRKO mice (Figure 3C).
The growth of PRKOmice and F/F mice fed normal chow was
observed for four months. PRKO mice had a leaner phenotype
than F/F mice and exhibited no further weight gain (Figures 3S
and 3T). At eight weeks of age, PRKO mice developed signifi-
cant hyperglycemia during fasting and feeding (fasting—PRKO,
348 6 61 mg/dl versus F/F, 98 6 6 mg/dl; p < 0.001; morning
fed—PRKO, 524 6 59 mg/dl versus F/F, 124 6 12 mg/dl;CELL METABOLISM : JANUARY 2006p < 0.001; Figure 3U), which was accompanied by notably de-
creased plasma insulin concentrations (fasting—PRKO, below
detection limit versus F/F, 0.486 0.07 ng/ml; p < 0.001; morning
fed—PRKO 0.04 6 0.03 ng/ml versus F/F, 1.35 6 0.25 ng/ml;
p = 0.0013; Figure 3V). At this age, the mutant mice showed
polyuria and polydipsia, and some appeared lethargic. Daily
food intake increased in PRKO mice compared with control
mice (PRKO, 8.3 6 0.6 g/24 hr versus F/F, 4.1 6 0.3 g/24 hr;
p < 0.001; Figure 3W), which corresponded to diabetic hyper-
phagia. Thus, PRKO mice exhibited characteristics typical of
diabetes with defective insulin secretion. Furthermore, PRKO
mice had lower serum amylase activities than F/F mice (PRKO,
711 6 58 U/dl versus F/F, 1121 6 67 U/dl; p = 0.0015; Fig-
ure 3X), presumably due to pancreatic hypoplasia and severe
diabetes.61
S H O R T A R T I C L EFigure 3. The adult PRKO mouse has a small pancreas, few islets, and low insulin content, which result in overt diabetes
A and B) Small pancreas in an adult PRKO mouse. Gut regions were dissected (A), and pancreatic weights were measured at 12 weeks of age (B).
C–E) Fewer islets and reduced endocrine cell mass in PRKO mice. Pancreatic sections from 10-week-old F/F mice and PRKO mice were immunostained for insulin and
glucagon (C) to determine the number of islets (D), b cell area (E), and a cell area (E), which were normalized to total pancreatic area.
F) Lower pancreatic insulin content in PRKO mice. Pancreatic insulin content was measured in acid-ethanol extracts from 6-week-old F/F mice and PRKO mice.
G–R) Duct-associated endocrine cells in PRKO mice. HE staining (G and H) and immunostaining (I–R) of serial pancreatic sections from 8-week-old F/F and PRKO mice.
The number of b cells was markedly reduced (J). Endocrine cells are located close to ductal structures (J, L, N, and P).
S and T)Growth retardation in PRKOmice. Gross appearances (S) of 6-day-old (left) and 3-week-old (right) PRKOmice (bottom) and control littermates (top). Growth curve
(T) for litters obtained from mating F/F mice and PRKO mice.
U–W) Insulin-deficient diabetes in PRKO mice. Blood glucose concentrations (U) and plasma insulin concentrations (V) from fasted and random-fed 8-week-old male F/F
mice and PRKO mice. Food intake (W) was measured for 24 hr from 16-week-old male F/F mice and PRKO mice.
X) Exocrine pancreatic insufficiency in F/F Rip.cre mice. Amylase activity was measured in serum from F/F mice and PRKO mice at 10 weeks of age.
Bars represent means 6 SE of n = 4–8 mice. Levels of significance (Student’s t test) are shown (*p < 0.05; **p < 0.01; ***p< 0.001).b cell-specific Rbp-j KO (bRKO) mice have normal b cell
number and function
By crossing F/F mice with Rip.cre mice, we next generated
b cell-specific Rbp-j KO (Rbp-jf/f Rip.cre, designated as bRKO)62mice (Figure S6). bRKO mice had normal body weight (bRKO,
35.2 6 2.6 mg/dl versus Rip.cre, 37.0 6 2.5 mg/dl; p = 0.62;
Figure 4A). No significant differences were detected in the
levels of blood glucose (bRKO, 160 6 17 mg/dl versus Rip.cre,CELL METABOLISM : JANUARY 2006
Role of Rbp-j in pancreas development159 6 15 mg/dl; p = 0.95; Figure 4B) or plasma insulin (bRKO,
2.78 6 1.10 ng/ml versus Rip.cre, 2.67 6 0.55 ng/ml; p = 0.92;
Figure 4C) in the fed state. Hematoxylin-eosin (HE) staining and
immunohistochemical studies with glucagon, insulin, Pdx1, so-
matostatin, PP, pan-CK, and amylase revealed no abnormalities
(Figure 4D). These data indicate that Rbp-j is not required for
maintaining b cell function or b cell mass.
Discussion
Using the stage-specific conditional gene targeting approach,
we documented the effects of Notch/Rbp-j signaling on pancre-
atic development and function.
Normally, Ngn3 expression peaks between E13.5 and E15.5
(Apelqvist et al., 1999). In PRKOmice, Ngn3 expression peaked
at E10.5 and then declined at E11.5 (Figure 1), which suggests
that termination of Notch signaling results in earlier commitment
to endocrine cell lineages and earlier loss of endocrine progen-
itor cells. Before E12.5, the majority of endocrine cells formed
are a and PP cells, and a wave of b and d cell generation occurs
after E13 (Pictet and Rutter, 1972; Murtaugh and Melton, 2003).
In PRKO mice, a and PP cell differentiation was enhanced at
Figure 4. Absence of abnormalities in b cell-specific Rbp-j KO mice
A–C) Metabolic parameters of bRKO mice. Body weight (B), random-fed blood
glucose concentrations (C), and random-fed plasma insulin concentrations (D)
of 19-week-old male Rip.cre mice and bRKO mice.
D) Absence of morphological changes in the pancreas of the bRKOmouse. Immu-
nohistochemistry of serial pancreatic sections of 20-week-old Rip.cre mice and
bRKO mice.
Bars represent means 6 SE of n = 7–8 mice. Levels of significance (Student’s
t test) are shown (NS, not significant).CELL METABOLISM : JANUARY 2006E11.5, but b and d cell differentiation was not enhanced. It
was recently reported that Ngn3 protein transduction to E11.5
pancreatic cells resulted in a cell differentiation, but the trans-
duction to E15 cells resulted in b cell differentiation (Domi-
nguez-Bendala et al., 2005). In agreement with that report, our
findings suggest that E11 proendocrine cells may lack some
factor that contributes to b or d cell differentiation.
Tubular structures with CK+ DBA+ cells dominated in the pan-
creas of the PRKO mouse at later embryonic stages (Figure 2).
Thus, residual Pdx1+ epithelial cells that have not undergone
endocrine cell differentiation have a tendency to differentiate
into ductal cells. A study demonstrated that genes that partici-
pate in the Notch pathway are upregulated in the metaplastic
ductal epithelium of pancreatic premalignant legions (Miyamoto
et al., 2003). Lineage-tracing studies show that ductal lineage
is separated from Pdx1+ Ngn32 common pancreatic progenitor
cells between E9.5 and E12.5 (Gu et al., 2002); those are
the times when the disruption of Rbp-j genes in PRKO mice
occurs. These findings suggest that the appropriate downregu-
lation of Notch signaling is necessary for pancreatic duct cell
identity.
In the mutant mouse, the number of Pdx1-positive cells
clearly decreased before E15 and the pancreas was small there-
after (Figures 2B0, 3A, and 3B). If the role of Notch signaling is
simply to regulate cell fate, hypoplasia of certain types of cell
should be accompanied by hyperplasia of other types of cell.
For instance, in the determination of T and B lymphocytes,
loss of function of Notch1 resulted in blockade of T cell develop-
ment and enhancement of B cell production, while overexpres-
sion of Notch1 resulted in blockade of B cell lymphopoiesis and
the generation of T cells (Pui et al., 1999;Wilson et al., 2001). The
small pancreas and altered pancreatic cell composition in our
mutant mouse suggest that defective Notch signaling allows
premature differentiation of a, PP, and duct cells at the expense
of later differentiating b, d, and acinar cells. This mode of regu-
lation is reminiscent of neuronal differentiation, in which Notch/
Rbp-j signaling acts as a gatekeeper between self-renewal and
commitment (Ishibashi et al., 1995).
In PRKO mice, though inadequate, the differentiation and
growth of acinar cells occurred after E15. Persistent Notch ICD
expression in pancreatic epithelium has been shown to inhibit
acinar cell differentiation (Hald et al., 2003; Esni et al., 2004),
and generalized Hes1 KO mice showed increased acinar cell
growth (Jensen et al., 2000a). These results also suggest that
Notch signaling inhibits acinar cell differentiation and prolifera-
tion during later embryonic stages.
The role of Notch signaling in terminally differentiated cells is
unknown, although it was speculated that Notch might confer
some degree of plasticity on postmitotic neurons (Ahmad
et al., 1995). We detected the expression of Notch2 and Dll1
in endocrine cells of adult mice (data not shown). Furthermore,
Ngn3+ endocrine progenitor cells were shown to reside within
the pancreatic islets (Gu et al., 2002); however, we found no dif-
ference between bRKO mice and control mice (Figure 4). It was
reported that the b cells in adult islets are mainly formed by self-
duplication of preexisting b cells and that the forced expression
of Notch1 ICD in the adult pancreas does not perturb mature
endocrine cells (Murtaugh et al., 2003; Dor et al., 2004). To-
gether with the results of PRKO mice, Notch signaling may be
indispensable only during the early developmental stages of
the pancreas.63
S H O R T A R T I C L EOur data show that Rbp-j is a key molecule in the propagation
of pancreatic progenitor cells and is essential for proper differ-
entiation into mature pancreatic cells.
Experimental procedures
Generation of pancreas- or b cell-specific Rbp-j KO mice
The generations of mice bearing a floxed allele of Rbp-j have been described
previously (Han et al., 2002). Pdx.cremice in which Cre recombinase is under
the transcriptional control of the mouse Pdx1 promoter were gifts from
Dr. Douglas A. Melton (Gu et al., 2002). Rip.cre mice in which Cre recombi-
nase is under the control of the rat insulin II promoter were purchased from
the Jackson Laboratory. Mice homozygous for the floxed Rbp-j allele (F/F)
were crossed with Pdx.cre or Rip.cre transgenic mice. The resultant double-
heterozygous mice were then crossed with Rbp-jf/+mice, resulting in Rbp-jf/f
Pdx.cre (PRKO) or Rbp-jf/f Rip.cre (bRKO) mice and their control littermates.
Genotyping and assessment of deletion efficiency were performed by South-
ern blot analyses on genomic DNA obtained from tails or other tissues.
Histological analyses
Whole embryos or excised pancreas were fixed with 4% paraformaldehyde
in PBS for overnight at 4ºC then paraffin embedded, and 5 mm sections were
cut and mounted on glass slides. Slides were dewaxed, rehydrated, and, in
some instances, subjected to antigen retrieval by autoclaving at 121ºC for
five minutes with 10 mM citrate buffer. Endogenous peroxidase was inacti-
vated with 0.3% H2O2 in methanol for 30 min. The slides were blocked for
1 hr with a reagent containing casein (DAKO Protein Block Serum-Free
Solution; Dako), then stained overnight with the following primary antibodies
(Abs): rabbit anti-Pdx1 (Guz et al., 1995), rabbit anti-Hes1 (Jensen et al.,
2000a), rabbit anti-Ngn3 (Schwitzgebel et al., 2000), guinea pig anti-Insulin
(Dako), rabbit anti-Glucagon (Dako), rabbit anti-Somatostatin (Dako), rabbit
anti-PP (Dako), rabbit anti-Ghrelin (Kojima et al., 1999), rabbit anti-pHH3
(Cell Signaling Technology), rabbit anti-pan-CK (Santa Cruz), rabbit anti-
Amylase (Sigma-Aldrich), rabbit anti-Glut2 (Thorens et al., 1992), mouse
anti-ISL1 (Developmental Studies Hybridoma Bank). The slides were washed
with PBS the following day and incubated for 2 hr with the following second-
ary antibodies: biotinylated goat anti-guinea pig IgG; biotinylated goat anti-
rabbit IgG, and biotinylated rabbit anti-goat IgG (all from Vector). The slides
were then incubated with avidin-biotin complex (ABC) reagent (Vectastain
Elite ABC Kit; Vector) for 50min followed by the addition of diaminobenzidine
tetrahydrochloride (DAB) (Dako) as a substrate-chromogen solution. After
hematoxylin counterstaining anddehydration, slidesweremounted inmount-
ingmedium (MGK-S; Matsunami) and pictures were taken using an Axioskop
Microscope (Carl Zeiss). Morphometric analyses of pancreas were carried
out using the Scion Image analysis program (Scion). The number of islets
was calculated, with the definition of an islet as a group of endocrine cells
containing at least five visible nuclei. The endocrine cell mass was calculated
as the ratio of each hormone-positive cell area to the total area of the pan-
creas section. An In situ Apoptosis Detection Kit (Takara) was used for
TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end la-
beling) assays, and tissue taken from the involutingmammary gland of a post-
lactating female Wistar rat was used as a positive control for apoptosis.
Counterstaining of these sections was performed with methyl green. For
E15 embryos, in situ hybridization of Hes1 was carried out using digoxige-
nin-labeled cRNA probes according to the reported protocol (Tomita et al.,
2000).
Analysis of metabolic parameters
Blood glucose values were determined from whole venous blood taken from
mouse tails using an automatic glucometer (Glutest Ace, Sanwa Kagaku) or
an enzyme colorimetric assay kit (Glucose CII test, Wako). Blood for insulin
and amylase was taken by retroorbital bleeds. Plasma insulin levels were
measured using an ELISA kit (Morinaga). For glucagon, blood samples
were collected into tubes containing EDTA (1 mg/ml blood) and aprotinin
(500 KIE/ml blood). For measurements of pancreatic insulin contents, pan-
creas were quickly dissected, weighed, and frozen in liquid nitrogen. Insulin
was extracted by mechanical homogenization in iced acid ethanol. After
24 hr at 4ºC, samples were centrifuged, and the supernatant was collected
and stored at 220ºC. Insulin concentrations were determined by ELISA.
Amylase activity was measured according to the Caraway method using64a kit (Amylase-Test Wako, Wako). All values are expressed as mean 6 stan-
dard error.
Supplemental data
Supplemental Data include six figures, Supplemental Results, and Supple-
mental Experimental Procedures and can be found with this article online
at http://www.cellmetabolism.org/cgi/content/full/3/1/59/DC1/.
Acknowledgments
We thank Dr. Douglas A. Melton for providing Pdx.cre mice, Dr. Christopher
V.E. Wright for anti-Pdx1 Ab, Dr. Michael S. German for anti-Ngn3 Ab,
Dr. Bernard Thorens for anti-Glut2 Ab, Dr. Kenji Kangawa for anti-Ghrelin
Ab, and Ryoichiro Kageyama for anti-Hes1 Ab. This work was supported
by research grants from the Japanese Ministry of Education, Culture, Sports,
Science, and Technology and the Japanese Ministry of Health, Labor and
Welfare.
Received: August 2, 2005
Revised: October 30, 2005
Accepted: December 16, 2005
Published: January 10, 2006
References
Ahlgren, U., Pfaff, S.L., Jessell, T.M., Edlund, T., and Edlund, H. (1997). Inde-
pendent requirement for ISL1 in formation of pancreatic mesenchyme and
islet cells. Nature 385, 257–260.
Ahmad, I., Zaqouras, P., and Artavanis-Tsakonas, S. (1995). Involvement of
Notch-1 in mammalian retinal neurogenesis: association of Notch-1 activity
with both immature and terminally differentiated cells. Mech. Dev. 53, 73–85.
Apelqvist, A., Li, H., Sommer, L., Beatus, P., Anderson, D.J., Honjo, T., Hrabe
de Angelis, M., Lendahl, U., and Edlund, H. (1999). Notch signalling controls
pancreatic cell differentiation. Nature 400, 877–881.
Dominguez-Bendala, J., Klein, D., Ribeiro, M., Ricordi, C., Inverardi, L.,
Pastori, R., and Edlund, H. (2005). TAT-mediated neurogenin 3 protein trans-
duction stimulates pancreatic endocrine differentiation in vitro. Diabetes 54,
720–726.
Dor, Y., Brown, J., Martinez, O.I., and Melton, D.A. (2004). Adult pancreatic
beta-cells are formed by self-duplication rather than stem-cell differentiation.
Nature 429, 41–46.
Esni, F., Ghosh, B., Biankin, A.V., Lin, J.W., Albert, M.A., Yu, X., MacDonald,
R.J., Civin, C.I., Real, F.X., Pack, M.A., et al. (2004). Notch inhibits Ptf1 func-
tion and acinar cell differentiation in developing mouse and zebrafish pan-
creas. Development 131, 4213–4224.
Gradwohl, G., Dierich, A., LeMeur, M., and Guillemot, F. (2000). Neurogenin3
is required for the development of the four endocrine cell lineages of the pan-
creas. Proc. Natl. Acad. Sci. USA 97, 1607–1611.
Gu, G., Dubauskaite, J., andMelton, D.A. (2002). Direct evidence for the pan-
creatic lineage: NGN3+ cells are islet progenitors and are distinct from duct
progenitors. Development 129, 2447–2457.
Guz, Y., Montminy, M.R., Stein, R., Leonard, J., Gamer, L.W., Wright, C.V.E.,
and Teitelman, G. (1995). Expression of murine STF-1, a putative insulin gene
transcription factor, in b cells of pancreas, duodenal epithelium and pancre-
atic exocrine and endocrine progenitors during ontogeny. Development 121,
11–18.
Hald, J., Hjorth, J.P., German, M.S., Madsen, O.D., Serup, P., and Jensen, J.
(2003). Activated Notch1 prevents differentiation of pancreatic acinar cells
and attenuate endocrine development. Dev. Biol. 260, 426–437.
Hamada, Y., Kadokawa, Y., Okabe, M., Ikawa, M., Coleman, J.R., and
Tsujimoto, Y. (1999). Mutation in ankyrin repeats of the mouse Notch2
gene induces early embryonic lethality. Development 126, 3415–3424.CELL METABOLISM : JANUARY 2006
Role of Rbp-j in pancreas developmentHan, H., Tanigaki, K., Yamamoto, N., Kuroda, K., Yoshimoto, M., Nakahata,
T., Ikuta, K., and Honjo, T. (2002). Inducible gene knockout of transcription
factor recombination signal binding protein-J reveals its essential role in
T versus B lineage decision. Int. Immunol. 14, 637–645.
Heller, R.S., Jenny, M., Collombat, P., Mansouri, A., Tomasetto, C., Madsen,
O.D., Mellitzer, G., Gradwohl, G., and Serup, P. (2005). Genetic determinants
of pancreatic epsilon-cell development. Dev. Biol. 286, 217–224.
Hrabe´ de Angelis, M., McIntyre, J., II, and Gossler, A. (1997). Maintenance
of somite borders in mice requires the Delta homologue Dll1. Nature 386,
717–721.
Ishibashi, M., Ang, S.L., Shiota, K., Nakanishi, S., Kageyama, R., and Guille-
mot, F. (1995). Targeted disruption of mammalian hairy and Enhancer of split
homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors,
premature neurogenesis, and severe neural tube defects. Genes Dev. 9,
3136–3148.
Jensen, J., Pedersen, E.E., Galante, P., Hald, J., Heller, R.S., Ishibashi, M.,
Kageyama, R., Guillemot, F., Serup, P., and Madsen, O.D. (2000a). Control
of endodermal endocrine development by Hes-1. Nat. Genet. 24, 36–44.
Jensen, J., Heller, R.S., Funder-Nielsen, T., Pedersen, E.E., Lindsell, C.,
Weinmaster, G., Madsen, O.D., and Serup, P. (2000b). Independent develop-
ment of pancreatic alpha- and beta-cells from neurogenin3-expressing pre-
cursors: a role for the notch pathway in repression of premature differentia-
tion. Diabetes 49, 163–176.
Kageyama, R., and Ohtsuka, T. (1999). The Notch-Hes pathway in mamma-
lian neural development. Cell Res. 9, 179–188.
Kato, H., Sakai, T., Tamura, K., Minoguchi, S., Shirayoshi, Y., Hamada, Y.,
Tsujimoto, Y., and Honjo, T. (1996). Functional conservation of mouse Notch
receptor family members. FEBS Lett. 395, 221–224.
Kojima,M., Hosoda, H., Date, Y., Nakazato, M.,Matsuo, H., and Kangawa, K.
(1999). Ghrelin is a growth-hormone-releasing acylated peptide from stom-
ach. Nature 402, 656–660.
Lammert, E., Brown, J., andMelton, D.A. (2000). Notch gene expression dur-
ing pancreatic organogenesis. Mech. Dev. 94, 199–203.
Miyamoto, Y., Maitra, A., Ghosh, B., Zechner, U., Argani, P., Iacobuzio-
Donahue, C.A., Sriuranpong, V., Iso, T., Meszoely, I.M., Wolfe, M.S., et al.
(2003). Notch mediates TGF alpha-induced changes in epithelial differentia-
tion during pancreatic tumorigenesis. Cancer Cell 6, 565–576.
Murtaugh, L.C., andMelton, D.A. (2003). Genes, signals, and lineages in pan-
creas development. Annu. Rev. Cell Dev. Biol. 19, 71–89.CELL METABOLISM : JANUARY 2006Murtaugh, L.C., Stanger, B.Z., Kwan, K.M., and Melton, D.A. (2003). Notch
signaling controls multiple steps of pancreatic differentiation. Proc. Natl.
Acad. Sci. USA 100, 14920–14925.
Oka, C., Nakano, T., Wakeham, A., de la Pompa, J.L., Mori, C., Sakai, T.,
Okazaki, S., Kawaichi, M., Shiota, K., Mak, T.W., and Honjo, T. (1995).
Disruption of the mouse RBP-J kappa gene results in early embryonic death.
Development 121, 3291–3301.
Pang, K., Mukonoweshuro, C., and Wong, G.G. (1994). Beta cells arise from
glucose transporter type 2 (Glut2)-expressing epithelial cells of the develop-
ing rat pancreas. Proc. Natl. Acad. Sci. USA 91, 9559–9563.
Pictet, R., and Rutter, W.J. (1972). Development of the embryonic endocrine
pancreas. In Handbook of Physiology, Section 7, D.F. Steiner and N. Frenkel,
eds. (Baltimore, MD: Williams and Williams), pp. 25–66.
Pui, J.C., Allman, D., Xu, L., DeRocco, S., Karnell, F.G., Bakkour, S., Lee,
J.Y., Kadesch, T., Hardy, R.R., Aster, J.C., and Pear, W.S. (1999). Notch1 ex-
pression in early lymphopoiesis influences B versus T lineage determination.
Immunity 11, 299–308.
Schwitzgebel, V.M., Scheel, D.W., Conners, J.R., Kalamaras, J., Lee, J.E.,
Anderson, D.J., Sussel, L., Johnson, J.D., and German, M.S. (2000). Expres-
sion of neurogenin3 reveals an islet cell precursor population in the pancreas.
Development 127, 3533–3542.
Swiatek, P.J., Lindsell, C.E., del Amo, F.F., Weinmaster, G., and Gridley, T.
(1994). Notch1 is essential for postimplantation development in mice. Genes
Dev. 15, 707–719.
Thorens, B., Wu, Y.J., Leahy, J.L., and Weir, G.C. (1992). The loss of GLUT2
expression by glucose-unresponsive cells of db/db mice Is reversible and is
induced by the diabetic environment. J. Clin. Invest. 90, 77–85.
Tomita, K., Moriyoshi, K., Nakanishi, S., Guillemot, F., and Kageyama, R.
(2000). Mammalian achaete-scute and atonal homologs regulate neuronal
versus glial fate determination in the central nervous system. EMBO J. 19,
5460–5472.
Wilson, A., MacDonald, H.R., and Radtke, F. (2001). Notch 1-deficient com-
mon lymphoid precursors adopt a B cell fate in the thymus. J. Exp. Med. 194,
1003–1012.
Xue, Y., Gao, X., Lindsell, C.E., Norton, C.R., Chang, B., Hicks, C., Gendron-
Maguire, M., Rand, B., Weinmaster, G., and Gridley, T. (1999). Embryonic
lethality and vascular defects in mice lacking the Notch ligand Jagged1.
Hum. Mol. Genet. 8, 723–730.65
